170 related articles for article (PubMed ID: 29682747)
1. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.
Hioki M; Shimada T; Yuan T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Sawamoto K; Akashita G; Miyamoto KI; Ohta T; Tamai I; Shimada T; Sai Y
Biopharm Drug Dispos; 2018 May; 39(5):256-264. PubMed ID: 29682747
[TBL] [Abstract][Full Text] [Related]
2. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y
J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
4. Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer.
Achiwa H; Oguri T; Sato S; Maeda H; Niimi T; Ueda R
Cancer Sci; 2004 Sep; 95(9):753-7. PubMed ID: 15471562
[TBL] [Abstract][Full Text] [Related]
5. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.
Miller SR; Jilek JL; McGrath ME; Hau RK; Jennings EQ; Galligan JJ; Wright SH; Cherrington NJ
Pharmacol Res Perspect; 2021 Aug; 9(4):e00831. PubMed ID: 34288585
[TBL] [Abstract][Full Text] [Related]
6. Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.
Tsujie M; Nakamori S; Nakahira S; Takahashi Y; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Anticancer Res; 2007; 27(4B):2241-9. PubMed ID: 17695509
[TBL] [Abstract][Full Text] [Related]
7. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
8. Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial.
Sinn M; Riess H; Sinn BV; Stieler JM; Pelzer U; Striefler JK; Oettle H; Bahra M; Denkert C; Bläker H; Lohneis P
Eur J Cancer; 2015 Aug; 51(12):1546-54. PubMed ID: 26049689
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.
Mani RS; Hammond JR; Marjan JM; Graham KA; Young JD; Baldwin SA; Cass CE
J Biol Chem; 1998 Nov; 273(46):30818-25. PubMed ID: 9804860
[TBL] [Abstract][Full Text] [Related]
10. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
Ward JL; Sherali A; Mo ZP; Tse CM
J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
[TBL] [Abstract][Full Text] [Related]
12. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
13. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
Krys D; Hamann I; Wuest M; Wuest F
FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
[TBL] [Abstract][Full Text] [Related]
15. Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.
Eto K; Kawakami H; Kuwatani M; Kudo T; Abe Y; Kawahata S; Takasawa A; Fukuoka M; Matsuno Y; Asaka M; Sakamoto N
Br J Cancer; 2013 Apr; 108(7):1488-94. PubMed ID: 23492684
[TBL] [Abstract][Full Text] [Related]
16. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
[TBL] [Abstract][Full Text] [Related]
17. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.
Burke T; Lee S; Ferguson PJ; Hammond JR
J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397
[TBL] [Abstract][Full Text] [Related]
18. Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae.
Vickers MF; Zhang J; Visser F; Tackaberry T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):361-73. PubMed ID: 15043160
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy.
Morinaga S; Nakamura Y; Watanabe T; Mikayama H; Tamagawa H; Yamamoto N; Shiozawa M; Akaike M; Ohkawa S; Kameda Y; Miyagi Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S558-64. PubMed ID: 21913012
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression.
Guo Z; Wang F; Di Y; Yao L; Yu X; Fu D; Li J; Jin C
Int J Nanomedicine; 2018; 13():4869-4880. PubMed ID: 30214194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]